Comparative effectiveness of the BNT162b2 vs ChAdOx1 vaccine against Covid-19 medrxiv.org/content/10.110…

#EarlyCareerResearcher : Junqing Xie, University of Oxford, used #UKBiobank data to conduct a head-to-head comparison of BNT162b2 versus ChAdOx1 vaccines against #COVID19 in the UK Biobank cohort. #UKBSC22

Wow 😍 📷 Instagram | Juncao_Oxford

In patients with osteoarthritis or back pain, there were no differential risks of incident #Covid_19 diagnosis or COVID-19 hospitalisation for #ibuprofen users compared with other ns-NSAIDs, COX-2i or paracetamol. link.springer.com/article/10.100…

People often focus on treating various COVID complications, yet overlook that a healthier daily life could actually prevent many. Hope our findings may help shift the spotlight🚵‍♀️. Grateful to my supervisor and esteemed researchers.@prieto_alhambra @RutgerWalls UK Biobank

Key promises of modern PGx: (1) Providing mechanistic insights into why drugs&vax are only effective or unsafe for a subset of people (2) Triangulating causal inference from RCT, RWE, to genetic evidence. See how we realise these through collaborative work in PED team.